Share This

Public company info - Shanghai Junshi Biosciences Co. Ltd. - H Shares , 01877.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shanghai Junshi Biosciences Co. Ltd. - H Shares, 01877.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -1,668,194 -504,292 -1,497,105 -1,186,623 -510,441 -347,019 -185,207
Net Cash Flow from Return on Investments & Servicing of Finance 32,993 8,507 -25,958 -31,537 1,441 2,649 3,032
　Interest Received 58,299 30,979 20,278 29,222 4,097 2,649 3,070
　Interest Paid -25,551 -22,472 -46,236 -60,759 -2,656 0 -38
　Dividend Received 245 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -107,131 -137,609 -1,701 -411 -317 -57 0
Net Cash Flow from Investing Activities -526,163 -1,911,931 -718,254 -981,252 -425,078 185,063 -720,246
　Additions to Fixed Assets -383,101 -772,346 -560,581 -791,585 -546,196 -263,721 -199,789
　Disposal of Fixed Assets 1 11 0 54 0 0 0
　Increase in Investments -102,264 -1,609,704 -175,137 -191,092 -403,500 -1,176,000 -1,150,410
　Decrease in Investments 0 565,284 3,006 72,200 515,024 1,610,346 683,687
　Net Cash Flow with Related Parties 199,750 895,000 0 1,108 0 0 0
　Others -240,549 -990,176 14,458 -71,937 9,594 14,438 -53,734
Net Cash Flow before Financing Activities -2,268,495 -2,545,325 -2,243,018 -2,199,823 -934,395 -159,364 -902,421
Net Cash Flow from Financing Activities 4,668,560 2,688,158 4,459,758 654,341 3,435,258 319,634 646,324
　New Loans 840,362 500,000 374,239 1,681,516 434,132 0 0
　Loans Repayment -154,260 -827,292 -423,685 -1,204,404 -106,000 0 -1,000
　Fixed Income/Debt Instruments 0 0 0 0 198,019 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 -200,000 0 0 0
　Equity Financing 3,782,708 2,120,450 4,509,204 376,121 2,909,107 319,634 647,324
　Net Cash Flow with Related Parties 199,750 895,000 0 1,108 0 0 0
　Others 0 0 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents 2,400,065 142,833 2,216,740 -1,545,482 2,500,863 160,270 -256,097
Cash & Cash Equivalents at Beginning of Year 3,504,605 3,384,998 1,214,026 2,763,570 266,298 111,387 363,928
Net Cash Flow due to Change in Exchange Rate/Others 92,266 -23,226 -45,768 -4,062 -3,591 -5,359 3,556
Cash & Cash Equivalents at End of Year 5,996,936 3,504,605 3,384,998 1,214,026 2,763,570 266,298 111,387
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.